Provided by Tiger Trade Technology Pte. Ltd.

LMP Capital and Income Fund Inc

15.86
+0.06000.38%
Volume:31.87K
Turnover:504.37K
Market Cap:362.52M
PE:3.12
High:15.92
Open:15.72
Low:15.72
Close:15.80
52wk High:17.57
52wk Low:13.35
Shares:22.86M
Float Shares:22.86M
Volume Ratio:0.54
T/O Rate:0.14%
Dividend:1.43
Dividend Rate:9.03%
EPS(TTM):5.09
EPS(LYR):-0.0358
ROE:-0.24%
ROA:1.12%
PB:0.96
PE(LYR):-442.94

Loading ...

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

GlobeNewswire
·
Yesterday

Press Release: Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds

Dow Jones
·
Jan 30

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

GlobeNewswire
·
Jan 29

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

GlobeNewswire
·
Jan 12

Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026

GlobeNewswire
·
Jan 12

SeaStar Medical Announces 2026 Milestones

GlobeNewswire
·
Jan 07

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

GlobeNewswire
·
Jan 06

Press Release: LMP Capital and Income Fund Inc. (SCD or "the Fund"; CUSIP: 50208A102) Announces Notification of Sources of Distributions

Dow Jones
·
Dec 31, 2025

SeaStar Medical Announces 1-for-10 Reverse Split

GlobeNewswire
·
Dec 24, 2025

Vertex's Gene Therapy Works In Children With Blood Disorders

Benzinga
·
Dec 08, 2025

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
Dec 06, 2025

Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025

GlobeNewswire
·
Dec 02, 2025

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

GlobeNewswire
·
Dec 02, 2025

LMP Capital and Income Fund Declares November Distribution with Majority from Long-Term Capital Gains

Reuters
·
Dec 01, 2025

Press Release: LMP Capital and Income Fund Inc. (SCD or "the Fund"; CUSIP: 50208A102) Announces Notification of Sources of Distributions

Dow Jones
·
Dec 01, 2025

Press Release: BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Nov 24, 2025

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

GlobeNewswire
·
Nov 20, 2025

Press Release: SeaStar Medical Announces Appointment of Michael Messinger as CFO

Dow Jones
·
Nov 17, 2025

Press Release: Emmaus Life Sciences Reports Quarterly Financial Results

Dow Jones
·
Nov 15, 2025

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire
·
Nov 14, 2025